Laminar Distribution of Cannabinoid Receptor 1 in the Prefrontal Cortex of Nonhuman Primates.
Yingying Han, Qianyu Dong, Jiyun Peng, Baoming Li, Chong Sun, Chaolin Ma
Molecular Neurobiology July 2024 DOI: 10.1007/s12035-023-03828-4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational histochemical and protein-expression study in non-human primates Peer reviewed |
|---|---|
| Population | Monkey prefrontal cortex tissue, specifically Brodmann area 46 |
| Keywords | Cb1r Immunofluorescence histochemical Monkey Pfc Western blotting |
| Key findings | CB1R is highly expressed in the monkey prefrontal cortex, especially in area 46, where it shows a layered distribution with highest expression in the inner granular layer. CB1R+PV+ cells are widely distributed in layers II-VI of area 46, with layer IV showing notable prevalence. The authors propose that cannabis may modulate PFC activity via interneurons and that its side effects may arise from abnormal CB1R expression. |
Abstract
Cannabis is an annual herb of the genus Cannabis, with a history of medical use going back thousands of years. However, its abuse causes many side-effects, including confusion of consciousness, alienation, and mental disorders such as schizophrenia and depression. Research conducted on rodents suggests that there are two types of cannabinoid receptors-cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R). CB1R is found mostly in the central nervous system, particularly in the prefrontal cortex (PFC), and alterations in its expression in the PFC have been strongly linked to mental disorders. Within the layers of the PFC, Brodmann area 46 is associated with the processing of complex cognitive information. However, it remains unclear whether CB1R is expressed in the PFC 46 area of non-human primate. In this work, we applied western blotting along with immunofluorescent histochemical staining to investigate the distribution pattern of CB1R in the PFC of nonhuman primate, Our findings reveal that CB1R is highly expressed in the monkey PFC, especially in area 46. Furthermore, CB1R exhibits a layered distribution pattern within area 46 of the PFC, with the inner granular layer displaying the highest expression levels. Additionally, CB1R+PV+ cells are widely distributed in lay II-VI of area 46, with layer IV showing notable prevalence. In conclusion, CB1R is distributed in the PV interneurons in area 46 of the prefrontal cortex, particularly in layer IV, suggesting that cannabis may modulate PFC activities via regulating interneuron in the PFC. And cannabis-induced side effects may be caused by abnormal expression of CB1R.
Citations in the library
Cited by 2
- Decoding the Toxicity of Synthetic Cannabinoids: From Receptor Activation to Multiorgan Dysfunction. Medicinal Research Reviews June 24, 2026
- Perinatal omega-3 sex-selectively mitigates neuropsychiatric impacts of prenatal THC in the cortico-striatal-hippocampal circuit. Molecular Psychiatry November 2025
Cites 3
- Cannabinoid ‘model’ psychosis, dopamine–cannabinoid interactions and implications for schizophrenia Cambridge University Press eBooks May 27, 2004
- Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation. Journal of Clinical Psychopharmacology October 2014
- Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex. Brain Research March 25, 2011